HALO logo
halo search icon
Haemonetics Corporation
Haemonetics Corporation
HAE · NYS

Haemonetics Corporation

US$59.56

Price Arrow2.71 (4.77%)
20/05/2026 04:10:00 PM
All-CompaniesAll-ConsensusConsensus CheapEMA 125 BreakdownEngulfing BullishEngulfing Bullish (Realtime)Fakey Shakey - LongFakey Shakey - Long (Realtime)+3
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Haemonetics Corporation Overview

HAE Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Weak

Garp

Very Strong

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Strong

Balance Sheet

Weak

About HAE

icon

Telephone

1.781.848.7100

icon

Address

125 Summer Street, Boston, MA 02110

Description

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

HAE Price Chart

Key Stats

Market Cap

US$2.64B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 47.31 - 87.32

Trade Value (12mth)

US$13,328,481.00

1 week

0.99%

1 month

-5.58%

YTD

-28.92%

1 year

-15.05%

All time high

142.11

Key Fundamentals

EPS 3 yr Growth

113.90%

EBITDA Margin

28.40%

Operating Cashflow

$216m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

14.40

Quick Ratio

0.00

Other Data

Shares Outstanding (Fully Diluted)

46m

HALO Sector

Healthcare

Next Company Report Date

13-May-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

HAE Announcements

Latest Announcements

DateAnnouncements
20 May 26
20 May 26
07 May 26
07 May 26
02 May 26

HAE Fundamentals

Per Share Records

Historical data

Forecast data

USD2022202320242025202420252026202720282029
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock3.332.064.96locklocklock
EPS (Fully Diluted)
$locklocklocklock3.312.05N/Alocklocklock
Growth
%locklocklocklock43.7-38.1140.5locklocklock
PE
Xlocklocklocklock19.126.3N/Alocklocklock
EV/EBITDA
Xlocklocklocklock12.28.9N/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Haemonetics Corporation (HAE:NYS)?
Halo FAQ
The current share price of Haemonetics Corporation (HAE:NYS) is USD$59.56.
What is the 52-week high share price for Haemonetics Corporation (HAE:NYS)?
Halo FAQ
The 52-week high share price for Haemonetics Corporation (HAE:NYS) is USD$87.32.
What is the 52-week low share price for Haemonetics Corporation (HAE:NYS)?
Halo FAQ
The 52-week low share price for Haemonetics Corporation (HAE:NYS) is USD$47.31.
What is the dividend yield for Haemonetics Corporation (HAE:NYS)?
Halo FAQ
Haemonetics Corporation (HAE:NYS) does not pay a dividend.
What was Haemonetics Corporation (HAE:NYS) last dividend payment?
Halo FAQ
Haemonetics Corporation (HAE:NYS) does not pay a dividend.
What is the franking level for Haemonetics Corporation (HAE:NYS)?
Halo FAQ
Haemonetics Corporation (HAE:NYS) has a franking level of 0.00%.
In which sector is Haemonetics Corporation (HAE:NYS) classified?
Halo FAQ
Haemonetics Corporation (HAE:NYS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.